A Leftist Activist Group Helped Torpedo MDMA Therapy

Based on the article, Psymposia's misdeeds against MDMA therapy approval were:

1. Released critical podcast (2021) Exposed past therapist misconduct in early MDMA trials through a podcast series

2. Launched public petition (2024) Gathered signatures to delay FDA approval process, comparing MDMA risks to opioid painkillers

3. Organized FDA testimony (June 2024) Sent seven members to speak against approval at key FDA meeting without revealing their affiliations

4. Spread claims online Shared unverified abuse allegations through social media networks

5. Challenged research validity Pressured science journals to retract Lykos-funded MDMA studies

6. Criticized patient advocates Targeted trial participants who shared positive therapy experiences online

7. Lobbied drug evaluators Convinced independent review group ICER to call allegations "disturbing"

8. Split into new groups Original members formed new organizations to continue opposition efforts